Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration

The Spike protein of SARS-CoV-2, its receptor-binding domain (RBD), and its primary receptor ACE2 are extensively glycosylated. The impact of this post-translational modification on viral entry is yet unestablished. We expressed different glycoforms of the Spike-protein and ACE2 in CRISPR-Cas9 glyco...

Full description

Bibliographic Details
Main Authors: Qi Yang, Thomas A Hughes, Anju Kelkar, Xinheng Yu, Kai Cheng, Sheldon Park, Wei-Chiao Huang, Jonathan F Lovell, Sriram Neelamegham
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2020-10-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/61552